D. Isabel Petrescu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
D. Isabel Petrescu has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Bikesh Kumar Nirala
Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA 30322, USA
1 shared publication - Jason T. Yustein
Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA
1 shared publication - Taku Yamamichi
Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA 30322, USA
1 shared publication - Tasnuva N. Shafin
Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA 30322, USA
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis
Osteosarcoma (OS) is a heterogeneous, highly metastatic bone malignancy in children and adolescents. Despite advancements in multimodal treatment strategies, the prognosis for patients with metastatic or recurrent disease has not improved significantly in the last four decades. OS is a highly heterogeneous tumor; its genetic background and the mechanism of oncogenesis are not well defined. Unfortunately, no effective molecular targeted therapy is currently available for this disease. Understanding osteosarcoma’s tumor microenvironment (TME) has recently gained much interest among scientists hoping to provide valuable insights into tumor heterogeneity, progression, metastasis, and the identification of novel therapeutic avenues. Here, we review the current understanding of the TME of OS, including different cellular and noncellular components, their crosstalk with OS tumor cells, and their involvement in tumor progression and metastasis. We also highlight past/current clinical trials targeting the TME of OS for effective therapies and potential future therapeutic strategies with negligible adverse effects.
Top Cited PapersOpen AccessDecoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis
Osteosarcoma (OS) is a heterogeneous, highly metastatic bone malignancy in children and adolescents. Despite advancements in multimodal treatment strategies, the prognosis for patients with metastatic or recurrent disease has not improved significantly in the last four decades. OS is a highly heterogeneous tumor; its genetic background and the mechanism of oncogenesis are not well defined. Unfortunately, no effective molecular targeted therapy is currently available for this disease. Understanding osteosarcoma’s tumor microenvironment (TME) has recently gained much interest among scientists hoping to provide valuable insights into tumor heterogeneity, progression, metastasis, and the identification of novel therapeutic avenues. Here, we review the current understanding of the TME of OS, including different cellular and noncellular components, their crosstalk with OS tumor cells, and their involvement in tumor progression and metastasis. We also highlight past/current clinical trials targeting the TME of OS for effective therapies and potential future therapeutic strategies with negligible adverse effects.